The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gafarov V.V.

Institute of Internal and Preventive Medicine — Branch of Institute of Cytology and Genetics, Novosibirsk, Russia;
Collaborative laboratory of Cardiovascular Diseases Epidemiology, Novosibirsk, Russia

Voevoda M.I.

Research Institute of Therapy and Prophylactic Medicine, Siberian Branch of the Russian Academy of Medical Sciences;
City Clinical Hospital No1, Novosibirsk, Russia

Gromova E.A.

Institute of Internal and Preventive Medicine — Branch of Institute of Cytology and Genetics, Novosibirsk, Russia;
Collaborative laboratory of Cardiovascular Diseases Epidemiology, Novosibirsk, Russia

Maksimov V.N.

Research Institute of Therapy, Siberian Branch of the Russian Academy of Medical Sciences, Novosibirsk

Gagulin I.V.

Institute of Internal and Preventive Medicine — Branch of Institute of Cytology and Genetics, Novosibirsk, Russia;
Collaborative laboratory of Cardiovascular Diseases Epidemiology, Novosibirsk, Russia

Iudin N.S.

Institut tsitologii i genetiki SO RAN, Novosibirsk

Gafarova A.V.

Institute of Internal and Preventive Medicine — Branch of Institute of Cytology and Genetics, Novosibirsk, Russia;
Collaborative laboratory of Cardiovascular Diseases Epidemiology, Novosibirsk, Russia

Mishakova T.M.

Institut tsitologii i genetiki SO RAN, Novosibirsk

Genetic markers for trait anxiety as one of the risk factors for cardiovascular diseases (WHO-MONICA program, MONICA-Psychosocial subprogram)

Authors:

Gafarov V.V., Voevoda M.I., Gromova E.A., Maksimov V.N., Gagulin I.V., Iudin N.S., Gafarova A.V., Mishakova T.M.

More about the authors

Journal: Therapeutic Archive. 2013;85(4): 47‑51

Read: 2119 times


To cite this article:

Gafarov VV, Voevoda MI, Gromova EA, et al. . Genetic markers for trait anxiety as one of the risk factors for cardiovascular diseases (WHO-MONICA program, MONICA-Psychosocial subprogram). Therapeutic Archive. 2013;85(4):47‑51. (In Russ.)

Recommended articles:
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21

References:

  1. Akzhigitov R.G. Sovremennye tendentsii v ponimanii i lechenii trevozhnykh rasstroistv. Ros med zhurn 2002; 1: 43-45.
  2. Kolyutskaya E.V. Trevozhnye rasstroistva: diagnostika i terapiya. Zdorov'e Ukrainy 2006; 3: 17.
  3. Lapina N.S., Borovkov N.N. Trevozhno-depressivnye sostoyaniya u bol'nykh gastroezofageal'noi reflyuksnoi bolezn'yu. Klin med 2008; 2: 59-62.
  4. Raffety B., Smith R., Ptacek J. Facilitating and debilitating trait anxiety, situational anxiety and coping with an anticipated stressor: A process analysis. J Personal Social Psychol 1997; 72: 892-906.
  5. Spielberger C.D. Conceptual and methodological issues in anxiety research. In: C.D. Spielberger (ed.) Anxiety: current trends in theory and research (Vol. 2). NY: Academic Press 1972: 481-493.
  6. Komer R. Patopsikhologiya povedeniya. Narusheniya i patologii psikhiki. S-Peterburg: Praim-Evroznak 2007.
  7. Bouchard T.J., Loehlin J.C. Genes, Evolution, and Personality. Behavioral Gen 2001; 31: 3.
  8. Heninger G.R., Charney D.S. Monoamine receptor systems and anxiety disorders. Psychiatr Clin North Am 1988; 11: 309-26.
  9. Nutt D., Laurence C. Panic attacks: a neurochemical overview of models and mechanisms. Br J Psychiatry 1992; 160: 165-178.
  10. Roy-Byrne P.P., Uhde T.W., Sack D.A. et al. Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry 1986; 21: 849-853.
  11. Benjamin J., Osher Y., Belmaker R.H., Ebstein R. No significant associations between two dopamine receptor polymorphisms and normal temperament. Hum Psychopharmacol 1998; 13 (1): 11-15.
  12. de Brettes B., Berlin I., Laurent C. et al. The dopamine D2 receptor gene TaqI A polymorphism is not associated with novelty seeking, harm avoidance and re-ward dependence in healthy subjects. Eur Psychiatry 1998; 13:427-430.
  13. Eley T.C., Ball D. , Hill L. et al. Association study of extreme high and low neuroticism, with genetic markers for the dopaminergic system. Am J Med Genet 1997; 81 (6): 487.
  14. Noble E.P., Ozkaragoz T.Z., Ritchie T.L. et al. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet 1998; 81 (3): 257-267.
  15. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and Risk of Incident Coronary Heart Disease A Meta-Analysis. J Am Coll Cardiol 2010; 56: 38-46.
  16. Gafarov V.V., Pak V.A., Gagulin I.V., Gafarova A.V. Psikhologiya zdorov'ya naseleniya v Rossii. Novosibirsk: Izd-vo SO RAN 2000.
  17. Gafarov V.V., Pak V.A., Gagulin I.V., Gafarova A.V. Epidemiologiya i profilaktika khronicheskikh neinfektsionnykh zabolevanii v techenie 2-kh desyatiletii i v period sotsial'no-ekonomicheskogo krizisa v Rossii. Novosibirsk: Izd-vo SO RAN 2000.
  18. Gafarov V.V., Gagulin I.V. Epidemiologicheskii podkhod k issledovaniyu lichnostnoi trevozhnosti. Byul SO RAMN SSSR 1993; 3: 77-81.
  19. WHO Proposal for the Multinational Monitoring of Trends in cardiovascular disease. Geneva 1985.
  20. World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe 1988.
  21. World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe 1988.
  22. Spielberger C.D. Anxiety as an emotional state. In: C.D. Spielberger (Ed.), Anxiety: Current trends in theory and research. (Vol. 2). NY: Academic Press 1972: 24-49.
  23. Smit K., Kalko S., Kantor Ch. Pul's-elektroforez i metody raboty s bol'shimi molekulami DNK. Analiz genoma. Pod red. K. Deivisa. Per s angl. M: Mir 1990: 58-94.
  24. Maniatis T., Frich E., Sembruk Dzh. Metody geneticheskoi inzhenerii. Molekulyarnoe klonirovanie. M: Mir 1984.
  25. Nanko S., Hattori M., Ikeda K. et al. Dopamone D4 receptor polymorphism and schizophrenia. Lancet 1993; 341: 689-690.
  26. Mitchell R.J., Howlett S., Earl L. et al. Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations. HumBiol 2000; 72 (2): 295-304.
  27. Cox D.R. Regression Models and Life Tables. J Royal Statistical Society. Series B. 1972; 34: 187-220.
  28. Glants S. Mediko-biologicheskaya statistika. Per. s angl. M: Praktika 1999; 459.
  29. Gafarov V.V., Gromova E.A., Kabanov Yu.N., Gagulin I.V. Lichnost' i ee vzaimodeistvie s sotsial'noi sredoi: neprotorennaya doroga. Novosibirsk: Izd-vo SO RAN 2008.
  30. Gafarov V.V., Gromova E.A., Gagulin I.V., Pilipenko P.I. Programma VOZ "MONICA-psikhosotsial'naya": risk vozniknoveniya insul'ta i psikhosotsial'nye faktory (epidemiologicheskoe issledovanie). Nevrol i psikhiatr im. Korsakova. Prilozhenie: Insul't. 2004; 12: 40-45.
  31. Gafarov V., Gromova H., Gagulin I. et al. Arterial hypertenzsion, myocardial infarction and stroke: risk of development and psychosocial factors. J Alaska Med 2007; 49 (2): 114-116.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.